Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
Annals of Surgical Oncology|October 21, 2020
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung CancerTaichi Matsubara, Shinkichi Takamori, Naoki Haratake, et al.
Cancer Science|June 23, 2015
Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3Terufumi Kato, Hiroshige Yoshioka, Isamu Okamoto, et al.
Archives of Drug Information|July 19, 2011
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid TumorsTaito Esaki, Takashi Seto, Hiroshi Ariyama, et al.
Investigational New Drugs|February 1, 2024
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancerNaoyuki Nogami, Takaaki Tokito, Yoshitaka Zenke, et al.
Surgical Case Reports|October 6, 2017
A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case reportMasafumi Yamaguchi, Fumihiko Hirai, Kenichi Taguchi, et al.
Oncology|December 14, 2006
Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patientsRiichiroh Maruyama, Ryuichi Suemitsu, Tatsuro Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2011
[Interstitial pneumonitis]Fumihiko Hirai, Gouji Toyokawa, Taro Ohba, et al.
Surgery Today|April 24, 2013
Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significanceTaro Ohba, Gouji Toyokawa, Takuro Kometani, et al.
Anticancer Research|October 3, 2014
Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinomaFumihiko Hirai, Takashi Seto, Eiko Inamasu, et al.
Journal of Cancer Research and Clinical Oncology|January 2, 2021
Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitisTaichi Matsubara, Masafumi Yamaguchi, Mikako Jinnouchi, et al.
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
Annals of Surgical Oncology|October 21, 2020
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung CancerTaichi Matsubara, Shinkichi Takamori, Naoki Haratake, et al.
Cancer Science|June 23, 2015
Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3Terufumi Kato, Hiroshige Yoshioka, Isamu Okamoto, et al.
Archives of Drug Information|July 19, 2011
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid TumorsTaito Esaki, Takashi Seto, Hiroshi Ariyama, et al.
Investigational New Drugs|February 1, 2024
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancerNaoyuki Nogami, Takaaki Tokito, Yoshitaka Zenke, et al.
Surgical Case Reports|October 6, 2017
A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case reportMasafumi Yamaguchi, Fumihiko Hirai, Kenichi Taguchi, et al.
Oncology|December 14, 2006
Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patientsRiichiroh Maruyama, Ryuichi Suemitsu, Tatsuro Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2011
[Interstitial pneumonitis]Fumihiko Hirai, Gouji Toyokawa, Taro Ohba, et al.
Surgery Today|April 24, 2013
Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significanceTaro Ohba, Gouji Toyokawa, Takuro Kometani, et al.
Anticancer Research|October 3, 2014
Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinomaFumihiko Hirai, Takashi Seto, Eiko Inamasu, et al.
Journal of Cancer Research and Clinical Oncology|January 2, 2021
Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitisTaichi Matsubara, Masafumi Yamaguchi, Mikako Jinnouchi, et al.
Pageof 25